Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Tanta Medical Journal. 2007; 35 (October): 781-788
in English | IMEMR | ID: emr-118413

ABSTRACT

Obesity in children is associated with various cardiovascular risk factors as well as an increased cardiovascular disease morbidity and mortality in adulthood. Thrombomodulin, a glycoprotein with vasoprotective and anticoagulant properties, is located at the luminal endothelial cell surface. Its soluble form results from endothelial cell injury. The aim of this work was to study thrombomodulin as an early marker of endothelial cell injury in obese children. This study was done on 40 children: 20 obese and 20 non-obese control children. They were subjected to clinical examination and the following investigations, CBC, blood urea and serum creatinine, fasting blood glucose, serum cholesterol serum triglyceride, HDL-cholesterol, LDL- cholesterol and soluble thrombomodulin by ELISA. There was significant increase in blood pressure, fasting blood glucose, cholesterol, LDL-cholesterol, triglycerides and soluble thrombomodulin in obese children compared to control group [p < 0.05]. HDL-cholesterol was significantly lower in obese children compared to non-obese ones [p < 0.05]. There was significant positive correlation between blood pressure and plasma soluble thrombomodulin. From this study it could be concluded that obese children had more elevated blood pressure, fasting blood glucose and dyslipidemia. Soluble thrombomodulin was higher in obese children compared to controls. It was positively correlated with elevated blood pressure denoting endothelial cell injury in obese children


Subject(s)
Humans , Male , Female , Endothelial Cells/pathology , Thrombomodulin/blood , Biomarkers , Child , Body Mass Index , Blood Glucose , Blood Pressure , Cholesterol/blood , Triglycerides/blood , Lipids/blood
SELECTION OF CITATIONS
SEARCH DETAIL